<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38212464</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1529-2916</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Nature immunology</Title><ISOAbbreviation>Nat Immunol</ISOAbbreviation></Journal><ArticleTitle>Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2.</ArticleTitle><Pagination><StartPage>218</StartPage><EndPage>225</EndPage><MedlinePgn>218-225</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41590-023-01724-6</ELocationID><Abstract><AbstractText>Long COVID (LC) occurs after at least 10% of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, yet its etiology remains poorly understood. We used 'omic" assays and serology to deeply characterize the global and SARS-CoV-2-specific immunity in the blood of individuals with clear LC and non-LC clinical trajectories, 8&#x2009;months postinfection. We found that LC individuals exhibited systemic inflammation and immune dysregulation. This was evidenced by global differences in T cell subset distribution implying ongoing immune responses, as well as by sex-specific perturbations in cytolytic subsets. LC individuals displayed increased frequencies of CD4<sup>+</sup> T cells poised to migrate to inflamed tissues and exhausted SARS-CoV-2-specific CD8<sup>+</sup> T cells, higher levels of SARS-CoV-2 antibodies and a mis-coordination between their SARS-CoV-2-specific T and B cell responses. Our analysis suggested an improper crosstalk between the cellular and humoral adaptive immunity in LC, which can lead to immune dysregulation, inflammation and clinical symptoms associated with this debilitating condition.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Yin</LastName><ForeName>Kailin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Gladstone Institutes, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Peluso</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0003-0585-6230</Identifier><AffiliationInfo><Affiliation>Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Xiaoyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Gladstone Institutes, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Reuben</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Gladstone Institutes, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Min-Gyoung</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Gladstone Institutes, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neidleman</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Gladstone Institutes, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrew</LastName><ForeName>Alicer</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4909-0759</Identifier><AffiliationInfo><Affiliation>Gladstone Institutes, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Kyrlia C</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Gladstone Institutes, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Tongcui</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Gladstone Institutes, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoh</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anglin</LastName><ForeName>Khamal</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-6425-681X</Identifier><AffiliationInfo><Affiliation>Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Argueta</LastName><ForeName>Urania</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valdivieso</LastName><ForeName>Daisy</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-8048-3297</Identifier><AffiliationInfo><Affiliation>Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asare</LastName><ForeName>Kofi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deveau</LastName><ForeName>Tyler-Marie</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munter</LastName><ForeName>Sadie E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibrahim</LastName><ForeName>Rania</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>St&#xe4;ndker</LastName><ForeName>Ludger</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Core Facility Functional Peptidomics, Ulm University Medical Center, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldberg</LastName><ForeName>Sarah A</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0002-8642-1468</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sulggi A</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0003-1560-2250</Identifier><AffiliationInfo><Affiliation>Zuckerberg San Francisco General Hospital and the University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>Kara L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Division of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>J Daniel</ForeName><Initials>JD</Initials><Identifier Source="ORCID">0000-0002-7616-0321</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Jeffrey N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;nch</LastName><ForeName>Jan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-7316-7141</Identifier><AffiliationInfo><Affiliation>Core Facility Functional Peptidomics, Ulm University Medical Center, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deeks</LastName><ForeName>Steven G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henrich</LastName><ForeName>Timothy J</ForeName><Initials>TJ</Initials><Identifier Source="ORCID">0000-0002-6684-0622</Identifier><AffiliationInfo><Affiliation>Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA, USA. timothy.henrich@ucsf.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roan</LastName><ForeName>Nadia R</ForeName><Initials>NR</Initials><Identifier Source="ORCID">0000-0002-5464-1976</Identifier><AffiliationInfo><Affiliation>Gladstone Institutes, University of California, San Francisco, San Francisco, CA, USA. nadia.roan@gladstone.ucsf.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, University of California, San Francisco, San Francisco, CA, USA. nadia.roan@gladstone.ucsf.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI158013</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK063720</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 AI157875</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24 AI174971</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 RR028962</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 OD018040</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 AI147159</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 AI126521</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 AI146268</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI159260</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI141003</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Immunol</MedlineTA><NlmUniqueID>100941354</NlmUniqueID><ISSNLinking>1529-2908</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>bioRxiv. 2023 Aug 04:2023.02.09.527892. doi: 10.1101/2023.02.09.527892</RefSource><PMID Version="1">36798286</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056724" MajorTopicYN="N">Immunity, Humoral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>M.J.P. reports consulting fees from Gilead Sciences and AstraZeneca, outside the submitted work. S.G.D. reports grants and/or personal fees from Gilead Sciences, Merck &amp; Co., Viiv, AbbVie, Eli Lilly, ByroLogyx and Enochian Biosciences, outside the submitted work. T.J.H. receives grant support from Merck and consults for Roche. All other authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>12</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>11</Day><Hour>23</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38212464</ArticleId><ArticleId IdType="pmc">PMC10834368</ArticleId><ArticleId IdType="doi">10.1038/s41590-023-01724-6</ArticleId><ArticleId IdType="pii">10.1038/s41590-023-01724-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma T, et al. Protracted yet coordinated differentiation of long-lived SARS-CoV-2-specific CD8+ T cells during convalescence. J. Immunol. 2021;207:1344&#x2013;1356. doi: 10.4049/jimmunol.2100465.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2100465</ArticleId><ArticleId IdType="pmc">PMC8763019</ArticleId><ArticleId IdType="pubmed">34389625</ArticleId></ArticleIdList></Reference><Reference><Citation>Neidleman J, et al. SARS-CoV-2-specific T cells exhibit phenotypic features of helper function, lack of terminal differentiation, and high proliferation potential. Cell Rep. Med. 2020;1:100081. doi: 10.1016/j.xcrm.2020.100081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2020.100081</ArticleId><ArticleId IdType="pmc">PMC7437502</ArticleId><ArticleId IdType="pubmed">32839763</ArticleId></ArticleIdList></Reference><Reference><Citation>Neidleman J, et al. Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19. Cell Rep. 2021;36:109414. doi: 10.1016/j.celrep.2021.109414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109414</ArticleId><ArticleId IdType="pmc">PMC8238659</ArticleId><ArticleId IdType="pubmed">34260965</ArticleId></ArticleIdList></Reference><Reference><Citation>Neidleman J, et al. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status. eLife. 2021;10:e72619. doi: 10.7554/eLife.72619.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.72619</ArticleId><ArticleId IdType="pmc">PMC8545397</ArticleId><ArticleId IdType="pubmed">34636722</ArticleId></ArticleIdList></Reference><Reference><Citation>Suryawanshi RK, et al. Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination. Nature. 2022;607:351&#x2013;355. doi: 10.1038/s41586-022-04865-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04865-0</ArticleId><ArticleId IdType="pmc">PMC9279157</ArticleId><ArticleId IdType="pubmed">35584773</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, et al. Persistence, magnitude, and patterns of postacute symptoms and quality of life following onset of SARS-CoV-2 infection: cohort description and approaches for measurement. Open Forum Infect. Dis. 2022;9:ofab640. doi: 10.1093/ofid/ofab640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab640</ArticleId><ArticleId IdType="pmc">PMC8755302</ArticleId><ArticleId IdType="pubmed">35106317</ArticleId></ArticleIdList></Reference><Reference><Citation>Rydyznski Moderbacher C, et al. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell. 2020;183:996&#x2013;1012. doi: 10.1016/j.cell.2020.09.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.038</ArticleId><ArticleId IdType="pmc">PMC7494270</ArticleId><ArticleId IdType="pubmed">33010815</ArticleId></ArticleIdList></Reference><Reference><Citation>Files JK, et al. Duration of post-COVID-19 symptoms is associated with sustained SARS-CoV-2-specific immune responses. JCI Insight. 2021;6:e151544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8410022</ArticleId><ArticleId IdType="pubmed">34143754</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma, T. et al. Post-acute immunological and behavioral sequelae in mice after Omicron infection. Preprint at bioRxiv10.1101/2023.06.05.543758 (2023).</Citation></Reference><Reference><Citation>Krishna BA, et al. Evidence of previous SARS-CoV-2 infection in seronegative patients with long COVID. EBioMedicine. 2022;81:104129. doi: 10.1016/j.ebiom.2022.104129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104129</ArticleId><ArticleId IdType="pmc">PMC9235296</ArticleId><ArticleId IdType="pubmed">35772216</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan O, et al. TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion. Nature. 2019;571:211&#x2013;218. doi: 10.1038/s41586-019-1325-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1325-x</ArticleId><ArticleId IdType="pmc">PMC6713202</ArticleId><ArticleId IdType="pubmed">31207603</ArticleId></ArticleIdList></Reference><Reference><Citation>Devine RD, Behbehani GK. Use of the pyrimidine analog, 5-iodo-2&#x2032;-deoxyuridine (IdU) with cell cycle markers to establish cell cycle phases in a mass cytometry platform. J. Vis. Exp. 2021 doi: 10.3791/60556.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/60556</ArticleId><ArticleId IdType="pubmed">34747407</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus. www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 (2021).</Citation></Reference><Reference><Citation>Peluso MJ, et al. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2021;36:109518. doi: 10.1016/j.celrep.2021.109518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109518</ArticleId><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferretti AP, et al. Unbiased screens show CD8+ T cells of COVID-19 patients recognize shared epitopes in SARS-CoV-2 that largely reside outside the spike protein. Immunity. 2020;53:1095&#x2013;1107. doi: 10.1016/j.immuni.2020.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.10.006</ArticleId><ArticleId IdType="pmc">PMC7574860</ArticleId><ArticleId IdType="pubmed">33128877</ArticleId></ArticleIdList></Reference><Reference><Citation>Costantini A, et al. Effects of cryopreservation on lymphocyte immunophenotype and function. J. Immunol. Methods. 2003;278:145&#x2013;155. doi: 10.1016/S0022-1759(03)00202-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-1759(03)00202-3</ArticleId><ArticleId IdType="pubmed">12957403</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavrois M, et al. Mass cytometric analysis of HIV entry, replication, and remodeling in tissue CD4+ T cells. Cell Rep. 2017;20:984&#x2013;998. doi: 10.1016/j.celrep.2017.06.087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.06.087</ArticleId><ArticleId IdType="pmc">PMC5560086</ArticleId><ArticleId IdType="pubmed">28746881</ArticleId></ArticleIdList></Reference><Reference><Citation>Neidleman J, et al. Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir. eLife. 2020;9:e60933. doi: 10.7554/eLife.60933.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.60933</ArticleId><ArticleId IdType="pmc">PMC7524554</ArticleId><ArticleId IdType="pubmed">32990219</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner S, et al. SARS-CoV-2 T cell response in severe and fatal COVID-19 in primary antibody deficiency patients without specific humoral immunity. Front. Immunol. 2022;13:840126. doi: 10.3389/fimmu.2022.840126.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.840126</ArticleId><ArticleId IdType="pmc">PMC8960624</ArticleId><ArticleId IdType="pubmed">35359967</ArticleId></ArticleIdList></Reference><Reference><Citation>Roederer M, Nozzi JL, Nason MC. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A. 2011;79:167&#x2013;174. doi: 10.1002/cyto.a.21015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cyto.a.21015</ArticleId><ArticleId IdType="pmc">PMC3072288</ArticleId><ArticleId IdType="pubmed">21265010</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Y, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573&#x2013;3587. doi: 10.1016/j.cell.2021.04.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.04.048</ArticleId><ArticleId IdType="pmc">PMC8238499</ArticleId><ArticleId IdType="pubmed">34062119</ArticleId></ArticleIdList></Reference><Reference><Citation>Korsunsky I, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods. 2019;16:1289&#x2013;1296. doi: 10.1038/s41592-019-0619-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-019-0619-0</ArticleId><ArticleId IdType="pmc">PMC6884693</ArticleId><ArticleId IdType="pubmed">31740819</ArticleId></ArticleIdList></Reference><Reference><Citation>Breiman L. Random forests. Mach. Learn. 2001;45:5&#x2013;32. doi: 10.1023/A:1010933404324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1010933404324</ArticleId></ArticleIdList></Reference><Reference><Citation>George AF, et al. Deep phenotypic analysis of blood and lymphoid T and NK cells from HIV+ controllers and ART-suppressed individuals. Front. Immunol. 2022;13:803417. doi: 10.3389/fimmu.2022.803417.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.803417</ArticleId><ArticleId IdType="pmc">PMC8829545</ArticleId><ArticleId IdType="pubmed">35154118</ArticleId></ArticleIdList></Reference><Reference><Citation>Bates, D., M&#xe4;chler, M., Bolker, B. &amp; Walker, S. Fitting linear mixed-effects models using lme4. J. Stat. Softw.10.48550/arXiv.1406.5823 (2015).</Citation></Reference><Reference><Citation>Lenth, R., Singmann, H., Love, J., Buerkner, P. &amp; Herve, M. Emmeans: estimated marginal means, aka least-squares means. R. package version 1 https://github.com/rvlenth/emmeans (2018).</Citation></Reference><Reference><Citation>Dobin A, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15&#x2013;21. doi: 10.1093/bioinformatics/bts635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:1&#x2013;21. doi: 10.1186/s13059-014-0550-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Laan M, Pollard K. A new algorithm for hybrid clustering of gene expression data with visualization and the bootstrap. J. Stat. Plan Inference. 2003;117:275&#x2013;303. doi: 10.1016/S0378-3758(02)00388-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0378-3758(02)00388-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng GX, et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 2017;8:14049. doi: 10.1038/ncomms14049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms14049</ArticleId><ArticleId IdType="pmc">PMC5241818</ArticleId><ArticleId IdType="pubmed">28091601</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahlmann-Eltze C, Huber W. glmGamPoi: fitting Gamma-Poisson generalized linear models on single cell count data. Bioinformatics. 2020;36:5701&#x2013;5702. doi: 10.1093/bioinformatics/btaa1009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btaa1009</ArticleId><ArticleId IdType="pmc">PMC8023675</ArticleId><ArticleId IdType="pubmed">33295604</ArticleId></ArticleIdList></Reference><Reference><Citation>Blondel VD, Guillaume J-L, Lambiotte R, Lefebvre E. Fast unfolding of communities in large networks. J. Stat. Mech. Theory Exp. 2008;2008:P10008. doi: 10.1088/1742-5468/2008/10/P10008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1088/1742-5468/2008/10/P10008</ArticleId></ArticleIdList></Reference><Reference><Citation>McGinnis CS, et al. No detectable alloreactive transcriptional responses under standard sample preparation conditions during donor-multiplexed single-cell RNA sequencing of peripheral blood mononuclear cells. BMC Biol. 2021;19:10. doi: 10.1186/s12915-020-00941-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12915-020-00941-x</ArticleId><ArticleId IdType="pmc">PMC7816397</ArticleId><ArticleId IdType="pubmed">33472616</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu C, et al. Comprehensive multi-omics single-cell data integration reveals greater heterogeneity in the human immune system. iScience. 2022;25:105123. doi: 10.1016/j.isci.2022.105123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.105123</ArticleId><ArticleId IdType="pmc">PMC9523353</ArticleId><ArticleId IdType="pubmed">36185375</ArticleId></ArticleIdList></Reference><Reference><Citation>Ianevski A, Giri AK, Aittokallio T. Fully-automated and ultra-fast cell-type identification using specific marker combinations from single-cell transcriptomic data. Nat. Commun. 2022;13:1246. doi: 10.1038/s41467-022-28803-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28803-w</ArticleId><ArticleId IdType="pmc">PMC8913782</ArticleId><ArticleId IdType="pubmed">35273156</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139&#x2013;140. doi: 10.1093/bioinformatics/btp616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp616</ArticleId><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm SA. A simple sequentially rejective multiple test procedure. Scand. J. Stat. 1979;6:65&#x2013;70.</Citation></Reference><Reference><Citation>Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Methodol. 1995;57:289&#x2013;300.</Citation></Reference><Reference><Citation>Crowell, H., Germain, P., Soneson, C., Sonrel, A. &amp; Robinson, M. muscat: multi-sample multi-group scRNA-seq data analysis tools. R package version 1.14.10. https://github.com/HelenaLC/muscat (2023).</Citation></Reference><Reference><Citation>Blighe, K., Rana, S. &amp; Lewis, M. Publication-ready volcano plots with enhanced colouring and labeling. R package version 1.18.10. https://github.com/kevinblighe/EnhancedVolcano (2020).</Citation></Reference><Reference><Citation>Huber W, et al. Orchestrating high-throughput genomic analysis with Bioconductor. Nat. Methods. 2015;12:115&#x2013;121. doi: 10.1038/nmeth.3252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3252</ArticleId><ArticleId IdType="pmc">PMC4509590</ArticleId><ArticleId IdType="pubmed">25633503</ArticleId></ArticleIdList></Reference><Reference><Citation>The Gene Ontology Consortium The gene ontology resource: 20 years and still going strong. Nucleic Acids Res. 2019;47:D330&#x2013;D338. doi: 10.1093/nar/gky1055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1055</ArticleId><ArticleId IdType="pmc">PMC6323945</ArticleId><ArticleId IdType="pubmed">30395331</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebrahimpoor M, Spitali P, Hettne K, Tsonaka R, Goeman J. Simultaneous enrichment analysis of all possible gene-sets: unifying self-contained and competitive methods. Brief. Bioinform. 2020;21:1302&#x2013;1312. doi: 10.1093/bib/bbz074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbz074</ArticleId><ArticleId IdType="pmc">PMC7373179</ArticleId><ArticleId IdType="pubmed">31297505</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebrahimpoor, M. rSEA: simultaneous enrichment analysis. R package version 2.1.1. CRAN.R-project.org/package=rSEA (2020).</Citation></Reference><Reference><Citation>Assarsson E, et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS ONE. 2014;9:e95192. doi: 10.1371/journal.pone.0095192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0095192</ArticleId><ArticleId IdType="pmc">PMC3995906</ArticleId><ArticleId IdType="pubmed">24755770</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolde, R. pheatmap: Pretty Heatmaps. R package version 1.0.12. https://github.com/raivokolde/pheatmap (2018).</Citation></Reference><Reference><Citation>Doncheva NT, Morris JH, Gorodkin J, Jensen LJ. Cytoscape StringApp: network analysis and visualization of proteomics data. J. Proteome Res. 2018;18:623&#x2013;632. doi: 10.1021/acs.jproteome.8b00702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.8b00702</ArticleId><ArticleId IdType="pmc">PMC6800166</ArticleId><ArticleId IdType="pubmed">30450911</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon P, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498&#x2013;2504. doi: 10.1101/gr.1239303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.1239303</ArticleId><ArticleId IdType="pmc">PMC403769</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>